Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07821125

Urotherapy Education for Families of Children With Duchenne Muscular Dystrophy

This study aims to investigate the effects of urotherapy education provided to families of children with Duchenne muscular dystrophy on parents' knowledge, lifestyle changes, and satisfaction with the education. Families will receive an online urotherapy education session covering lower urinary tract function, bladder and bowel habits, appropriate toileting behaviors, lifestyle recommendations, and related management strategies. Parents' knowledge and awareness will be assessed before the education, immediately after the education, and two weeks later. Satisfaction with the education will also be evaluated after the session.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Duchenne Muscular Dystrophy (DMD) Congenital, Hereditary, and Neonatal Diseases and Abnormalities Genetic Diseases, Inborn Genetic Diseases, X-Linked Lower Urinary Tract Symptoms Lower Urinary Tract Symptoms (LUTS) Muscular Diseases Muscular Disorders, Atrophic Muscular Dystrophies Muscular Dystrophy, Duchenne Musculoskeletal Diseases Nervous System Diseases Neuromuscular Diseases Pathological Conditions, Signs and Symptoms Signs and Symptoms Urological Manifestations

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Lokman Hekim University, Ankara, Ankara

Ankara, 06370, Turkey (Türkiye)

Location contact

Demet Öztürk, Phd

CONTACT

[email protected]

05068394288

About this study

Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disorder that may also be accompanied by lower urinary tract symptoms. Urotherapy is a conservative, non-pharmacological approach that includes education on bladder and bowel function, appropriate voiding and defecation habits, lifestyle modifications, and strategies for managing lower urinary tract symptoms.

This prospective interventional study will evaluate the effects of an online urotherapy education program provided to families of children with DMD. The education will be delivered remotely in a single session of approximately three hours. Participants will be assessed before the education, immediately after the education, and two weeks later and 2 months after. The study will examine changes in parents' knowledge and awareness of urotherapy-related behaviors and lifestyle practices, as well as their satisfaction with the education provided.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being a parent or caregiver of a child diagnosed with Duchenne muscular dystrophy.
  • Volunteering to participate in the study.
  • Providing informed consent.
  • Being able to participate in the online urotherapy education and complete the study assessments.

Exclusion criteria

  • Not completing the urotherapy education session.
  • Not completing the required study assessments.

Treatment and study plan

Urotherapy Education

Behavioral

Participants will receive a single online urotherapy education session lasting approximately three hours. The education will include information about lower urinary tract anatomy and function, lower urinary tract symptoms, bladder and bowel habits, appropriate voiding and defecation postures, scheduled voiding and defecation, fluid intake, lifestyle modifications, pelvic floor muscle awareness, and general strategies for managing lower urinary tract symptoms. Educational materials may include visual materials, videos, and other supporting resources.

Primary outcomes

  1. Change in Urotherapy Knowledge Level

    Time frame: Baseline, two weeks after, 8 weeks after

    Parents' knowledge of urotherapy will be assessed using a 10-item knowledge test developed by the researchers based on the educational content. The test consists of five true/false and five multiple-choice questions. Each correct answer is worth 10 points, resulting in a total score ranging from 0 to 100. Higher scores indicate a higher level of knowledge about urotherapy.

Secondary outcomes

  1. Change in Urotherapy-Related Lifestyle Behaviors

    Time frame: After 2 weeks and 8 weeks

    Urotherapy-related lifestyle behaviors will be assessed using awareness questions developed by the researchers. The questions evaluate voiding frequency, defecation frequency, daily water intake, consumption of tea, coffee, and carbonated beverages, appropriate toileting posture, and implementation of lifestyle recommendations introduced during the urotherapy education. Changes in these behaviors after the education will be evaluated.

  2. Satisfaction With Urotherapy Education

    Time frame: Baseline

    Satisfaction with the urotherapy education will be assessed using an 8-item satisfaction questionnaire developed by the researchers. Each item is rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). The total score ranges from 8 to 40, with higher scores indicating greater satisfaction with the education.

Study contacts

Contact information is provided by the study sponsor or research team.

Demet Öztürk, Phd

CONTACT

[email protected]

905068394288

Sponsors and collaborators

Lead sponsor

Lokman Hekim University

Other Gov

Registry information

Official study title

Effects of Urotherapy Education Provided to Families of Children With Duchenne Muscular Dystrophy on Knowledge, Lifestyle Changes, and Training Satisfaction

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Sep 15, 2026
Registry last updated
Sep 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.